Abstract:Background To address intraoperative bleeding in cardiac surgery, reducing blood transfusion requirements, is mandatory to achieve effective hemostasis. Hemostatic agents may limit localized persistent bleeding. The introduction of carboxymethyl-chitosan component into the hemostatic agent and the application of the radiation crosslinking technique maintain its capacity for achieving intraoperative hemostasis, thus increasing the clinical utility. Methods A prospective, noninferiority and randomized controlled clinical trial to compare the safety and efficacy of absorbable macroporous polysaccharide composites (AMPC, treatment group) with compound microporous polysaccharide hemostatic powder (CMPHP, control group) (2:1 ratio) as adjuncts to hemostasis in open surgery. The main indication was used for hemostasis in various traumatic hemorrhage areas, including cardiothoracic, vascular, and general surgery. The primary endpoint was success rate of hemostasis within 300 s (at a 10% noninferiority margin). The secondary endpoint was hemostasis time. Both endpoints were assessed in the modified intention-to-treat (MITT) population. Safety parameters were assessed. This study is fully compliant with the CONSORT statement. Results Randomized patients in AMPC and CMPHP groups were 168 and 84, respectively. In MITT population, the success rates of hemostasis within 300 s were 98.8% (163 of 165) in AMPC and 94.0% (78 of 83) in CMPHP (treatment difference 4.8% [95% CI -0.57% to 10.20%]). AMPC was thus noninferior to CMPHP. Hemostasis time (median [interquartile range]) with AMPC (87 [52.5, 180] s) was better than CMPHP (110 [54.5, 181] s). Changes in laboratory parameters over time and shifts to abnormal values were typical of surgeries and similar between two groups. No noticeable adverse effects associated with AMPC or CMPHP were observed. Conclusions AMPC is well tolerated as topical hemostatic agent, noninferior to commercial CMPHP, and exhibits excellent safety. This study provides a novel hemostatic agent which appears to offer significant clinical advantage in various hemorrhage areas.

S1575: Nanopowders Are Highly Effective in Achieving Hemostasis in Severe Peptic Ulcer Bleeding: an Interim Report of a Prospective Human Trial

Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding.

S3808 Hemostatic Peptides: An Effective Tool for Managing Bleeding When Traditional Options Are Challenging

Randomized controlled trial of hemostatic powder versus endoscopic clipping for non-variceal upper gastrointestinal bleeding

Evaluating the Efficacy of a Novel Hemostatic Powder Compared to Traditional Treatments in Non-Variceal Upper Gastrointestinal Bleeding: A Multicenter, Randomized Non-inferiority Study

TC-325 hemostatic powder versus current standard of care in managing malignant GI bleeding: a pilot randomized clinical trial

Efficacy of hemostatic powder monotherapy versus conventional endoscopic treatment for nonvariceal gastrointestinal bleeding: a meta-analysis and trial sequential analysis

962 an non-inferiority randomized controlled trial to compare hemostatic powder tc325 and standard therapy in bleeding from non-variceal upper gastrointestinal causes

98 AN NON-INFERIORITY RANDOMIZED CONTROLLED TRIAL TO COMPARE HEMOSTATIC POWDER TC325 AND STANDARD THERAPY IN BLEEDING FROM NON-VARICEAL UPPER GASTROINTESTINAL CAUSES

Adhesive Hemostatic Hydrogel with Ultrafast Gelation Arrests Acute Upper Gastrointestinal Hemorrhage in Pigs

TC-325 superiority in Malignant Gastrointestinal Bleeding – An Individual Patient Data Meta-analysis of Randomized Trials

Randomized Comparison of a Novel Hemostatic Clip (resolution Clip™) to Combined Epinephrine Injection and Heater Probe (HP) Thermocoagulation in Endoscopic Control of Peptic Ulcer Bleeding (PUB)

Hemostatic spray powder TC-325 in the primary endoscopic treatment of peptic ulcer-related bleeding: multicenter international registry

Silk Fibroin-based Hemostatic Powders with Instant and Robust Adhesion Performance for Sutureless Sealing of Gastrointestinal Defects

Evaluating the safety and efficacy of a novel polysaccharide hemostatic system during surgery: A multicenter multispecialty prospective randomized controlled trial

Prospective, Randomized, Controlled, Noninferiority Clinical Trial to Evaluate the Safety and Efficacy of Absorbable Macroporous Polysaccharide Composites As Adjunct to Hemostasis During Open Surgery

Advancements in hemostatic strategies for managing upper gastrointestinal bleeding: A comprehensive review

Hemostatic Effect and Mechanism of Epidermal Growth Factor-Hemostatic Powder after Endoscopic Submucosal Dissection in a Porcine Model

Nano Hemostat Solution: Immediate Hemostasis at the Nanoscale

Swift Covalent Gelation Coupled with Robust Wet Adhesive Powder: A Novel Approach for Acute Massive Hemorrhage Control in Dynamic and High-Pressure Wound Environments

Advancements in endoscopic hemostasis for non-variceal upper gastrointestinal bleeding